Results

Anavex Life Sciences Corp.

03/31/2021 | Press release | Distributed by Public on 03/31/2021 05:07

Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease